Market Scenario:
Intensifying number of bile duct
cancer cases being diagnosed globally have fortified the need for cutting-edge
solutions in terms of procedure and medicines to treat the condition. Market
reports associated with the healthcare sector made accessible by Market
Research Future along with published reports on other sectors have been lately
put out along with a report on this industry. The market is anticipated to
develop at an increasing CAGR of 9.2 percent in the forecast period.
The mounting level of spending
being devoted to research for the treatment of bile duct cancer is positively
contributing to increasing the market share globally. This has allowed the
development of pioneering procedures to treat this form of cancer apart from
the traditional solution involving chemotherapy. Additionally, factors such as
growing healthcare expenses and mounting awareness for the disease are
projected to boost the progress of the market in the forecast period.
The global bile duct cancer
market is expected to grow at an approximate CAGR of 9.2% during the forecast
period.
Segmentation
The global bile duct cancer market is segmented on
the basis of types, diagnosis, treatment, and end users.
On the basis of types, the market is segmented into
intrahepatic, extrahepatic, and others.
On the basis of diagnosis, the market is segmented
into blood tests, abdominal imaging, surgery, and others. The diagnosis segment
by abdominal imaging is sub segmented into endoscopic retrograde
cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography
(PTC), magnetic resonance cholangiopancreatography (MRCP), and others.
On the basis of treatment, the market is segmented
into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub
segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.
On the basis of end users, the market is segmented
into hospital &clinics, academic institutes, research organizations and
others.
Regional Analysis
The Americas dominates the global bile duct cancer market owing to a well-developed
healthcare sector. Apart from this, increasing number of patients, increasing
healthcare expenditure have boosted the growth of the market in the Americas.
According to the Centers for Disease Control and Prevention, U.S. health care
spending in 2015, reached $3.2 trillion or $9,990 per person which accounted
for 17.8% of the total GDP.
Europe is the second largest bile duct cancer
market, which is followed by Asia Pacific. Availability of funds for research,
huge patient population and government support for research & development
drives the European market.
Asia Pacific is the fastest growing region for the
market due to the presence of a huge patient population, continuously
developing economies like India and China, and presence of huge opportunity in
the market. According to Indian Brand Equity Fund, the per capita healthcare
expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and
reach USD 68.6 by 2015.
Key
players for global bile duct cancer market
The key players for the global bile duct
cancer market are Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd
(Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries
Ltd. (Middle East), Eli Lilly and Company. (U.S.), Sanofi (Europe), Fresenius
Kabi AG (Europe), Mylan N.V. (U.S.), and others.
Detailed Table
of Contents:
1. Report Prologue
2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size
Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic
Indicators
4.6 Technology Trends
& Assessment
5. Market
Factor Analysis
…
Continued!
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research
Future
Office No. 528,
Amanora Chambers
Magarpatta Road,
Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845
9312
Email: sales@marketresearchfuture.com
